Noxopharm's NOXCOVID-1 trial BLOG

There is a new website blog from Professor Kelly.

Noxopharm's NOXCOVID-1 trial

Our aim is to shorten the course of the infection or reduce its severity. The anti-viral drug, remdesivir, can provide some benefit if taken early enough, and the anti-inflammatory drug, dexamethasone, can reduce the severity of the disease when given to people with advanced disease, but with the number of deaths from this pandemic approaching the one million mark and a growing number of people, including children, experiencing long-term disabilities, there remains a very significant need for more and better therapies.